Last updated on May 2019

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations


Find a site near you

Start Over

Mayo Clinic

Rochester, MN United States
  Connect »

Fox Chase Cancer Center

Philadelphia, PA United States
  Connect »

CHU

Yvoir, Belgium
  Connect »

Asan Medical Center

Seoul, Korea, Republic of
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »

Royal Marsden

London, United Kingdom
  Connect »